Does Fintepla Have a Patient Assistance Program?
Yes, Fintepla (finerenone) offers patient assistance through the Fintepla Savings Card and Co-Pay Program, administered by ZS Associates for Boehringer Ingelheim. Eligible commercially insured patients pay as little as $10 per 30-day supply, with a maximum annual savings of $13,200. No assistance appears available for government-insured patients like Medicare or Medicaid.[1][2]
Who Qualifies and How to Enroll?
U.S. residents with private insurance qualify if they have a valid prescription for Fintepla 10 mg or 20 mg tablets. Enrollment is online at fintepla.com/savings-support or by calling 1-833-FINTEPLA (1-833-346-8375). Providers can also submit digitally via the program's portal. Coverage starts immediately upon approval, with instant card activation via text or email.[1][3]
What If You Have No Insurance or Low Income?
Uninsured or underinsured patients may access free or discounted Fintepla through the Boehringer Ingelheim Patient Assistance Foundation (BIPAF), which provides medications at no cost for those at or below 200% of the federal poverty level (e.g., $30,120 for an individual in 2024). Apply at bipaf.org or call 1-800-556-8317; decisions take up to 30 days. BIPAF covers a one-year supply, renewable annually.[2][4]
How Does Cost Compare Without Assistance?
Fintepla's list price is about $565 per 30-day supply (20 mg dose). Without aid, out-of-pocket costs can exceed $500 monthly for insured patients due to deductibles. The savings card caps costs for eligible users, but high-deductible plans may still require upfront payments.[5]
Are There State or Competitor Alternatives?
Some states offer drug discount programs like Partnership for Prescription Assistance, which links to BIPAF. Competitors like Farxiga (dapagliflozin) have similar copay cards from AstraZeneca, reducing costs to $0 for eligible patients, but no direct generic exists for Fintepla yet.[6]
[1] Fintepla.com Savings & Support
[2] Boehringer Ingelheim Patient Assistance
[3] Fintepla HCP Resources
[4] BIPAF Application
[5] GoodRx Fintepla Pricing
[6] Partnership for Prescription Assistance